Minerva Neurosciences (NERV) Tops Q1 EPS by 57c

Minerva Neurosciences (NASDAQ: NERV) reported Q1 EPS of ($0.50), $0.57 better than the analyst estimate of ($1.07).

For earnings history and earnings-related data on Minerva Neurosciences (NERV) click here.

You May Also Be Interested In

• U.S. and Denmark close in on a Greenland deal - Reuters
• Lockheed Martin wins $871 million F-35 contract modification
• Anthropic delays planned IPO from October to November - WSJ